HomeCompareGZPHF vs O

GZPHF vs O: Dividend Comparison 2026

GZPHF yields 4.78% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GZPHF wins by $68.0K in total portfolio value
10 years
GZPHF
GZPHF
● Live price
4.78%
Share price
$2.34
Annual div
$0.11
5Y div CAGR
32.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.2K
Annual income
$29,184.44
Full GZPHF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — GZPHF vs O

📍 GZPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGZPHFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GZPHF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GZPHF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GZPHF
Annual income on $10K today (after 15% tax)
$406.66/yr
After 10yr DRIP, annual income (after tax)
$24,806.77/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, GZPHF beats the other by $20,469.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GZPHF + O for your $10,000?

GZPHF: 50%O: 50%
100% O50/50100% GZPHF
Portfolio after 10yr
$68.2K
Annual income
$17,143.59/yr
Blended yield
25.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

GZPHF
No analyst data
Altman Z
2.4
Piotroski
4/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GZPHF buys
0
O buys
14
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$O▲ Buy$1,001 - $15,0002025-08-05
Ro Khanna🏢 House$O▲ Buy$1,001 - $15,0002024-02-13
Ro Khanna🏢 House$O▼ Sell$1,001 - $15,0002023-11-03
Ro Khanna🏢 House$O▲ Buy$1,001 - $15,0002023-10-31
Ro Khanna🏢 House$O▼ Sell$1,001 - $15,0002023-09-06
Ro Khanna🏢 House$O▲ Buy$1,001 - $15,0002023-08-29
Ro Khanna🏢 House$O▲ Buy$1,001 - $15,0002023-06-29
Ro Khanna🏢 House$O▲ Buy$1,001 - $15,0002023-06-26
Ro Khanna🏢 House$O▼ Sell$1,001 - $15,0002023-05-19
Gary Peters🏛 Senate$O▲ Buy$15,001 - $50,0002023-03-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGZPHFO
Forward yield4.78%5.28%
Annual dividend / share$0.11$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32.3%15.1%
Portfolio after 10y$102.2K$34.2K
Annual income after 10y$29,184.44$5,102.74
Total dividends collected$73.4K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: GZPHF vs O ($10,000, DRIP)

YearGZPHF PortfolioGZPHF Income/yrO PortfolioO Income/yrGap
1← crossover$11,333$632.95$10,818$608.16+$515.00GZPHF
2$13,013$886.93$11,787$741.68+$1.2KGZPHF
3$15,183$1,259.23$12,946$911.00+$2.2KGZPHF
4$18,063$1,816.62$14,345$1,127.94+$3.7KGZPHF
5$21,999$2,672.13$16,056$1,409.05+$5.9KGZPHF
6$27,563$4,023.99$18,171$1,777.83+$9.4KGZPHF
7$35,726$6,233.83$20,820$2,268.21+$14.9KGZPHF
8$48,218$9,990.59$24,188$2,929.90+$24.0KGZPHF
9$68,265$16,671.91$28,533$3,837.11+$39.7KGZPHF
10$102,228$29,184.44$34,235$5,102.74+$68.0KGZPHF

GZPHF vs O: Complete Analysis 2026

GZPHFStock

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Full GZPHF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this GZPHF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GZPHF vs SCHDGZPHF vs JEPIGZPHF vs KOGZPHF vs MAINGZPHF vs STAGGZPHF vs ADCGZPHF vs NNNGZPHF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.